OXFD News and Press, Oxford Immunotec Global PLC From 05/19/20

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 19, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces the release of the T-SPOT Discovery SARS-CoV-2 test kit. This kit is for resear...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Oxford Immunotec Global PLC (OXFD) Q1 2020 Earnings Conference Call May 5, 2020 08:00 AM ET Company Participants Matt McLaughlin – Chief Financial Officer Peter Wrighton-Smith – Chief Executive Officer Conference Call Participants Doug Schenkel – Cowen ...

Image source: The Motley Fool. Oxford Immunotec Global PLC   (NASDAQ: OXFD) Q1 2020 Earnings Call May 5, 2020 , 8:00 a.m. ET Operator Continue reading

Gainers: Portola Pharmaceuticals (NASDAQ: PTLA ) +130% . More news on: Portola Pharmaceuticals, Inc., CleanSpark, Inc., Genprex, Inc., Stocks on the move, , Read more ...

Oxford Immunotec Global PLC ( OXFD -9.8% ) is down, albeit on below-average volume, after releasing Q1 results that came in shy of expectations. More news on: Oxford Immunotec Global PLC, Healthcare stocks news, Stocks on the move, Read more ...

Oxford Immunotec Global (NASDAQ: OXFD ): Q1 GAAP EPS of -$0.20 misses by $0.05 . More news on: Oxford Immunotec Global PLC, Earnings news and commentary, Healthcare stocks news, Read more ...

First quarter revenue of $13.9 million, a decrease of 6% compared to prior year period, due to the impact of COVID-19 in China Gross margins expanded 270bps to 74% Ended the quarter with $166 million of cash and cash equivalents OXFORD, United Kingdom and MARLBOROUGH, Mass., May ...

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it plans to release first quarter 2020 financial results before the open of the market on...

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 21, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced that it has successfully obtained re-registration of the T-SPOT. TB test in China.  The ...